Genital herpes

Sexually Transmitted Infections

Volumn 82, Issue SUPPL. 4, 2006, Pages

  Geretti, A M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CYTODIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; SAMPLING; SCREENING TEST; SEROLOGY; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; VIRUS DETECTION;

CELL CULTURE TECHNIQUES; DNA, VIRAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOASSAY; MALE; MASS SCREENING; POLYMERASE CHAIN REACTION; RECURRENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS;

EID: 33845898441     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2006.023200     Document Type: Short Survey

References (60)

1. www.hpa.org.uk/infections/topics_az/hiv_and_sti/sti-1,herpes/ epidemiology/epidemiology.htm (last accessed April 2004).
2. Woolley PD, Kudesia G. Incidence of herpes simplex virus type-1 and type-2 from patients with primary (first-attack) genital herpes in Sheffield. Int J STD AIDS 1990;1:184-6.
3. Ross JD, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1992. Genitourin Med 1993;69:381-3.
4. Tayal SC, Pattman RS. High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex in Newcastle upon Tyne 1983-92. Int J STD AIDS 1994;5:359-61.
5. Slomka MJ, Emery L, Munday PE, et al. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 1998;55:177-83.
6. Thompson C. Genital herpes simplex typing in genitourinary medicine: 1995-1999. Int J STD AIDS 2000;11:501-2.
7. Scoular A, Norrie J, Gillespie G, et al. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ 2002;324:1366-7.
8. Ramaswamy M, McDonald C, Sabin C, et al. The epidemiology of genital infection with herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in genitourinary medicine attendees in inner London. Sex Transm Infect 2005;81:306-8.
9. Corey L, Holmes KK. Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention. Ann Intern Med 1983;98:973-83.
10. Lafferty WE, Coombs RW, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-9.
11. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847-54.
12. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999;341:1432-8.
13. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131:14-20.
14. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342:844-50.
15. Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 2000;45(Suppl T3):1-8.
16. Engelberg R, Carrell D, Krantz E, et al. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 2003;30:174-7.
17. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52.
18. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999;12:1-8.
19. Cowan FM, Johnson AM, Ashley R, et al. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 1996;174:470-5.
20. Wald A. Testing for genital herpes: how, who, and why. Curr Clin Top Infect Dis 2002;22:166-80.
21. Munday PE, Vuddamalay J, Slomka MJ, et al. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes. Sex Transm Infect 1998;74:175-8.
22. Kinghorn GR. Type-specific serological testing for herpes simplex infection. Int J STD AIDS 1998;9:497-500.
23. Malkin JE. Herpes simplex virus. Who should be tested. Herpes 2002;9:31.
24. Copas AJ, Cowan FM, Cunningham AL, et al. An evidence based approach to testing for antibody to herpes simplex virus type 2. Sex Transm Infect 2002;78:430-4.
25. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186(Suppl 1):S3-28.
26. Mertz GJ, Schmidt O, Jourden JL, et al. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 1985;12:33-9.
27. Kimberlin DW. Advances in the treatment of neonatal herpes simplex infections. Rev Med Virol 2001;11:157-63.
28. Newton EA, Kuder JM. A model of the transmission and control of genital herpes. Sex Transm Dis 2000;27:363-70.
29. Corey L. Challenges in genital herpes simplex virus management. J Infect Dis 2002;186(Suppl 1):S29-33.
30. Corey L, Wald A, Patel R, et al. Once daily valaciclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.
31. Stanberry LR, Spruance SL, Cunningnam AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002;347:1652-61.
32. Ashley RL. Performance and use of HSV type-specific serology test kits. Herpes 2002;9:38-45.
33. Morrow RA, Friedrich D, Krantz E. Performance of the Focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes. J Clin Microbiol 2003;41:5212-4.
34. Van Dyck E, Buve A, Weiss HA, et al. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simples virus type 2 in African populations. J Clin Microbiol 2004;42:2961-5.
35. Gopal R, Gibbs T, Slomka MJ, et al. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa. J Virol Methods 2000;87:71-80.
36. www.herpeselect.com (accessed December 2002).
37. Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm Infect 2002;78:160-5.
38. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992;326:1533-9.
39. Geretti AM, Brown WD. National survey of diagnostic services for genital herpes. Sex Transm Infect 2005;81:316-7.
40. Scoular A, Gillespie G, Carman WF. Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect 2002;78:21-5.
41. Wald A, Huang ML, Carrell D, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003;188:1345-51.
42. Ramaswamy M, McDonald C, Smith M, et al. Diagnosis of genital herpes by real-time PCR in routine clinical practice. Sex Transm Infect 2004;80:406-10.
43. Slomka MJ, Emery L, Munday PE, et al. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 1998;55:177-83.
44. Koenig M, Reynolds KS, Aldous W, et al. Comparison of Light-Cycler PCR, enzyme immunoassay, and tissue culture for detection of herpes simplex virus. Diagn Microbiol Infect Dis 2001;40:107-10.
45. Burrows J, Nitsche A, Bayly B, et al. Detection and subtyping of herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture. BMC Microbiol 2002;2:12.
46. Aldea C, Alvarez CP, Folgueira L, et al. Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green I dye as the detection signal. J Clin Microbiol 2002;40:1060-2.
47. Van Doornum GJ, Guldemeester J, Osterhaus AD, et al. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003;41:576-80.
48. Schmutzhard J, Merete Riedel H, Zweygberg Wirgart B, et al. Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation. J Clin Virol 2004;29:120-6.
49. Lafferty WE, Krofft S, Remington M, et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population. J Clin Microbiol 1987;25:323-6.
50. Baker DA, Pavan-Langston D, Gonik B, et al. Multicenter clinical evaluation of the Du Pont Herpchek HSV ELISA, a new rapid diagnostic test for the direct detection of herpes simplex virus. Adv Exp Med Biol 1990;263:71-6.
51. Gleaves CA, Rice DH, Lee CF. Evaluation of an enzyme immunoassay for the detection of herpes simplex virus (HSV) antigen from clinical specimens in viral transport media. J Virol Methods 1990;28:133-9.
52. Kudesia G, Van Hegan A, Wake S, et al. Comparison of cell culture with an amplified enzyme immunoassay for diagnosing genital herpes simplex infection. J Clin Pathol 1991;44:778-80.
53. Sillis M. Clinical evaluation of enzyme immunoassay in rapid diagnosis of herpes simplex infections. J Clin Pathol 1992;45:165-7.
54. Cone RW, Swenson PD, Hobson AC, et al. Herpes simplex virus detection from genital lesions: a comparative study using antigen detection (HerpChek) and culture. J Clin Microbiol 1993;31:1774-6.
55. Rouse DJ, Stringer JSA. An appraisal of screening for maternal type-specific herpes simplex antibodies to prevent neonatal herpes. Am J Obstet Gynecol 2000;183:400-6.
56. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
57. Kinghorn GR. Debate: the argument for. Should all pregnant women be offered type-specific serological screening for HSV infection? Herpes 2002;9:46-7.
58. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203-9.
59. www.ihmf.org/guidelines/summary7.asp#Genital HSV (accessed Dec 2002).
60. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002;51:12-7.